Characteristics of Adults With Non-Hospitalized Severe Respiratory Illness: Findings From a COVID-19 Vaccine Effectiveness Evaluation in Kenya, 2022–2023
Radhika Gharpure, Young M. Yoo, Bryan O. Nyawanda, Raphael O. Anyango, Brian O. Onyando, Sidney Ogolla, Billy Ogwel, Eric Osoro, Philip Ngere, Samuel Kadivane, Nzisa Liku, Eva Leidman, Gideon O. Emukule, Richard Omore, Kathryn E. Lafond
{"title":"Characteristics of Adults With Non-Hospitalized Severe Respiratory Illness: Findings From a COVID-19 Vaccine Effectiveness Evaluation in Kenya, 2022–2023","authors":"Radhika Gharpure, Young M. Yoo, Bryan O. Nyawanda, Raphael O. Anyango, Brian O. Onyando, Sidney Ogolla, Billy Ogwel, Eric Osoro, Philip Ngere, Samuel Kadivane, Nzisa Liku, Eva Leidman, Gideon O. Emukule, Richard Omore, Kathryn E. Lafond","doi":"10.1111/irv.70145","DOIUrl":null,"url":null,"abstract":"<p>Studies suggest the burden of non-hospitalized severe respiratory illness might be substantial in Kenya. Using data from a Kenya COVID-19 vaccine effectiveness evaluation, we compared characteristics of patients aged ≥12 years who were hospitalized with severe respiratory illness to outpatients who were referred for hospitalization and declined (non-hospitalized). Symptom presentation and lung radiograph findings were similar among both groups, and patients in both were diagnosed with critical conditions, including acute respiratory distress syndrome (12% hospitalized; 4% non-hospitalized) and sepsis (10% both). Findings underscore the importance of including non-hospitalized severe illness when estimating the burden of disease for respiratory viruses.</p>","PeriodicalId":13544,"journal":{"name":"Influenza and Other Respiratory Viruses","volume":"19 8","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.70145","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Influenza and Other Respiratory Viruses","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/irv.70145","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Studies suggest the burden of non-hospitalized severe respiratory illness might be substantial in Kenya. Using data from a Kenya COVID-19 vaccine effectiveness evaluation, we compared characteristics of patients aged ≥12 years who were hospitalized with severe respiratory illness to outpatients who were referred for hospitalization and declined (non-hospitalized). Symptom presentation and lung radiograph findings were similar among both groups, and patients in both were diagnosed with critical conditions, including acute respiratory distress syndrome (12% hospitalized; 4% non-hospitalized) and sepsis (10% both). Findings underscore the importance of including non-hospitalized severe illness when estimating the burden of disease for respiratory viruses.
期刊介绍:
Influenza and Other Respiratory Viruses is the official journal of the International Society of Influenza and Other Respiratory Virus Diseases - an independent scientific professional society - dedicated to promoting the prevention, detection, treatment, and control of influenza and other respiratory virus diseases.
Influenza and Other Respiratory Viruses is an Open Access journal. Copyright on any research article published by Influenza and Other Respiratory Viruses is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified.